Advertisement
Screener

CENCORA, INC. (COR) Overview

CENCORA, INC. (COR) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 3.94; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 8.40; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual 2.87; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 3.52; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$240.10$265.12$292.75$323.25$356.94$394.132025-11-062026-11-06$108.38$141.81$185.55$242.79$317.68$415.672021-11-082026-11-06$65.58$99.36$150.56$228.12$345.65$523.722016-11-072026-11-06$13.05$28.14$60.64$130.72$281.76$607.322006-11-062026-11-06$2.38$7.21$21.89$66.46$201.78$612.621995-04-042026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$333.54
Previous close
$307.60
Change
$25.93
Change (%)
8.43%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

COR
-8.38%
S&P 500
(m)

1 year

COR
+0.61%
S&P 500
(m)

3 years

COR
+75.26%
S&P 500
(m)

5 years

COR
+166.85%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 3.94

2.794.245.697.138.5831 Mar 2025: estimate (m); actual 3.6831 Mar 2025(m)30 Jun 2025: estimate (m); actual 3.5230 Jun 2025(m)31 Dec 2025: estimate (m); actual 2.8731 Dec 2025(m)31 Mar 2026: estimate (m); actual 8.4031 Mar 2026(m)30 Jun 2026: estimate (m); actual 3.9430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)3.94(m)(m)
1 Jan 202631 Mar 2026(m)8.40(m)(m)
1 Oct 202531 Dec 2025(m)2.87(m)(m)
1 Apr 202530 Jun 2025(m)3.52(m)(m)
1 Jan 202531 Mar 2025(m)3.68(m)(m)

30 Sept 2025 ○ Estimate (m) ● Actual 7.96

7.317.668.018.368.7130 Sept 2021: estimate (m); actual 7.3930 Sept 2021(m)30 Sept 2022: estimate (m); actual 8.0430 Sept 2022(m)30 Sept 2023: estimate (m); actual 8.5330 Sept 2023(m)30 Sept 2024: estimate (m); actual 7.5330 Sept 2024(m)30 Sept 2025: estimate (m); actual 7.9630 Sept 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Oct 202430 Sept 2025(m)7.96(m)(m)
1 Oct 202330 Sept 2024(m)7.53(m)(m)
1 Oct 202230 Sept 2023(m)8.53(m)(m)
1 Oct 202130 Sept 2022(m)8.04(m)(m)
1 Oct 202030 Sept 2021(m)7.39(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 84.75B ■ Earnings 0.76B — Profit margin 0.90%

-10.31B-0.3%25.21B0.8%60.73B1.9%96.24B3.1%30 Jun 2025: revenue 80.66B; earnings 0.69B; profit margin 0.85%30 Jun 202531 Dec 2025: revenue 85.93B; earnings 0.56B; profit margin 0.65%31 Dec 202531 Mar 2026: revenue 78.36B; earnings 1.64B; profit margin 2.09%31 Mar 202630 Jun 2026: revenue 84.75B; earnings 0.76B; profit margin 0.90%30 Jun 2026

30 Sept 2025 ■ Revenue 321.33B ■ Earnings 1.55B — Profit margin 0.48%

-38.56B-0.5%94.26B0.2%227.08B1.0%359.89B1.7%30 Sept 2022: revenue 238.59B; earnings 1.70B; profit margin 0.71%30 Sept 202230 Sept 2023: revenue 262.17B; earnings 1.75B; profit margin 0.67%30 Sept 202330 Sept 2024: revenue 293.96B; earnings 1.51B; profit margin 0.51%30 Sept 202430 Sept 2025: revenue 321.33B; earnings 1.55B; profit margin 0.48%30 Sept 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$333.54(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$333.54High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning COR

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
46.00K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.29M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-2.17%*
Total return · month
-4.48%*
Total return · quarter
9.43%*
Total return · half year
-1.13%*
Total return · year to date
-8.38%*
Total return · 1 year
0.61%*
Total return · 3 years
75.26%*
Total return · 5 years
166.85%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

CENCORA, INC. Overview

View more →

(m)

(m)

SEC CIK
1140859
Industry (SIC)
5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Country of operation
United States
Business address
1 WEST FIRST AVENUE, CONSHOHOCKEN, Pennsylvania, 19428, United States
Fiscal year end
0930
Phone
610-727-7000

Similar stocks

Stock NameCountryMarket CapPE Ratio
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
MCKESSON CORP (MCK)United States$101.317B19.78
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B